mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.0005 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0008 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0009 |